Key result
MCF ≤24% is linked to a ~7-fold increase in 1-year cardiac death after TAVI.
Why the study?
In patients with severe AS, LVEF may remain preserved despite advanced myocardial remodeling, leaving the prognostic value of MCF for predicting 1-year cardiac death after TAVI to be evaluated.
Does a reduced myocardial contraction fraction (MCF ≤24%) predict 1-year cardiac death in patients with severe aortic stenosis undergoing TAVI?
Observational (n=419)
No
Does a reduced myocardial contraction fraction (MCF ≤24%) predict 1-year cardiac death in patients with severe aortic stenosis undergoing TAVI?
A myocardial contraction fraction ≤24% is a strong, independent echocardiographic predictor of 1-year cardiac death in patients undergoing TAVI for severe aortic stenosis.
Answers are grounded in this paper and cite their sources.
MCF ≤24% was associated with higher 1-year cardiac death after TAVI; hypothesis-generating for risk stratification and requires prospective validation.
OBJECTIVE: Myocardial contraction fraction (MCF) is a volumetric index of myocardial shortening that relates left ventricular stroke volume to myocardial volume. In patients with severe aortic stenosis (AS), left ventricular ejection fraction (LVEF) may remain preserved despite advanced myocardial remodeling. This study aimed to evaluate the prognostic value of MCF for predicting 1-year cardiac death in patients undergoing transcatheter aortic valve implantation (TAVI). METHOD: This retrospective, single-center study included 419 consecutive patients with severe AS who underwent TAVI at a tertiary center. MCF was calculated by dividing stroke volume by left ventricular myocardial volume and multiplying the result by 100. Left ventricular myocardial volume was derived by dividing left ventricular myocardial mass by the myocardial density, which was assumed to be 1.05 g/mL. The primary endpoint was 1-year cardiac death. Receiver operating characteristic (ROC) curve analysis was used to identify the optimal MCF cutoff value, and the patients were divided into low- and high-MCF groups according to this threshold. RESULTS: The ROC-derived MCF cutoff value for predicting 1-year cardiac death was 24%, with an area under the curve of 0.783 (95% CI, 0.716-0.851), a sensitivity of 78.1%, and a specificity of 71.8%. Patients with MCF≤24% had lower LVEF and stroke volume index values, higher myocardial mass index and pulmonary artery pressure values, and larger left ventricular diameters than those with MCF>24%. One-year cardiac death occurred in 32 patients (7.6%) and was significantly more frequent in the MCF≤24% group than in the MCF>24% group (18.7% vs. 2.5%; P < 0.001). In univariable Cox regression analysis, MCF≤24% was strongly associated with 1-year cardiac death. In multivariable analysis, higher MCF, evaluated as a continuous variable, remained independently associated with a lower risk of 1-year cardiac death. CONCLUSION: Reduced MCF was associated with adverse left ventricular remodeling and increased 1-year cardiac death after TAVI. MCF may provide additional prognostic information beyond conventional echocardiographic parameters in patients with severe AS undergoing TAVI.
No takes yet. Share an insight, caveat, or question.
Coşkun et al. (2026) conducted an observational in Severe aortic stenosis (n=419). Myocardial contraction fraction (MCF) ≤24% vs. Myocardial contraction fraction (MCF) >24% was evaluated on 1-year cardiac death (p=<0.001). Patients with a myocardial contraction fraction ≤24% had a higher rate of 1-year cardiac death compared to those with >24% after transcatheter aortic valve implantation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: